European Institute of Oncology / Istituto Europeo di Oncologia (IEO)

Research / Science organisation

Location: Milano / Mailand, Italy (IT)

ISNI: 0000000417570843

ROR: https://ror.org/02vr0ne26

Show on Map:

Publications

(79)

Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours (2021) Dawod M, Gordoa TA, Cives M, De Mestier L, Crona J, Spada F, Oberg K, et al. Journal article, Review article Seroprevalence of SARS-CoV2 in IBD patients treated with biologic therapy (2021) Berte R, Mazza S, Stefanucci MR, Noviello D, Costa S, Ciafardini C, Mileti E, et al. Journal article Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? (2021) Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, et al. Journal article Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment (2021) Lamarca A, Cives M, De Mestier L, Crona J, Spada F, Oberg K, Pavel ME, Alonso-Gordoa T Journal article, Review article Consensus on molecular imaging and theranostics in neuroendocrine neoplasms (2021) Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, et al. Journal article, Review article Advanced small intestine well-differentiated neuroendocrine tumors (WD-SiNET): A survey of practice on 3rd line treatment (2021) Lamarca A, Cives M, De Mestier L, Crona J, Spada F, Oberg K, Pavel ME, Alonso-Gordoa T Conference contribution Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition (2021) Rogiers A, Da Silva IP, Tentori C, Tondini CA, Grimes JM, Trager MH, Nahm S, et al. Journal article Association of quality of life (QOL) with overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA-3 (ML-3) and ML-7 trials (2021) Fasching P, Harbeck N, Jerusalem G, Colleoni MA, Neven P, Franke F, De Laurentiis M, et al. Conference contribution Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trials (2021) Fazio N, Carnaghi C, Buzzoni R, Valle JW, Herbst F, Ridolfi A, Strosberg J, et al. Journal article Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ (2021) Baudin E, Caplin M, Garcia-Carbonero R, Fazio N, Ferolla P, Filosso PL, Frilling A, et al. Journal article

‹ 1 2 3 4 5 ... 8 ›